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1. Introduction 
After the introduction of the implantable cardioverter defibrillator (ICD) in clinical practice 
by Mirowski in 1980 [Mirowski et al., 1980] the first available devices offered only a basic 
ventricular pacing option. Since approximately 5-20% of  patients with an indication for ICD 
therapy following implantation criteria at that time (secondary prevention) needed 
antibradycardia pacing as well, the implantation of an additional pacemaker (PM) was often 
necessary up to the 1990s  [Sticherling et al., 1997; Brooks et al, 1995; Geiger et al., 1997]. In 
contrast, the modern ICD systems offer all forms of antitachycardia and antibradycardia 
therapy integrated in one device. However in 1997 Sticherling et al. concluded in their 
review about combined ICD and antibradycardia pacing therapy, that even with the 
introduction of integrated devices the issue of interactions will stay clinically relevant, as 
many candidates for ICD implantation present with an already implanted pacemaker 
system [Sticherling et al., 1997]. In contrast to this prediction, today more than 10 years later, 
through the tremendous advances in device technology as well as in implantation  and 
revision operation methods,  the patients are rare, who are fitted with two separate active 
cardiac implantable electronic devices (CIED) for antibradycardia and antitachycardia 
therapy respectively.  However these patients require extreme diligence at implantation, 
testing, programming and follow-up to avoid potentially dangerous interactions between 
the devices.  
„Concomitant implantation of AICD and a permanent pacemaker requires an understanding of the 
functioning of both devices and their potential interactions“[Singer et al., 1988] 
2. Indications and how to avoid simultaneous use of two active CIEDs 
As mentioned above, the CIEDs available today offer all known antibradycardia and 
antitachycardia therapies including cardiac resynchronization therapy (CRT). Thus it is 
possible to provide each patient at first implantation with an adequate singular device 
according to his rhythmological indication.  Today there is no indication for the primary 
simultaneous implantation of two separate CIEDs!  
However the situation remains complex in patients, who were already treated with one 
CIED, but need a system upgrade in the further course due to different reasons. Currently 
typical clinical indications are the need for antitachycardia and/or cardiac 
resynchronization therapy in pacemaker patients.  
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In these particular cases careful preparation and planning of the operative procedure is 
extremely important. The pulse generator pocket and the scar need to be assessed. Before 
operation the function and position of old leads are reviewed and a decision is made 
regarding which leads will be continued to be used, be abandoned or extracted.   
An essential requirement for ipsilateral implantation of new leads is an open vascular access 
route. In 25-33% of patients with an implanted device, a significant stenosis (> 50% stenosis) 
or even occlusion of the involved axillary, subclavian, brachiocephalic vein or superior vena 
cava (SVC) is encountered [Minden & Butter, 2008]. Therefore a periphereal phlebography 
should be performed before an upgrading procedure. Blood flow from the distal periphery, 
possible access sites, central draining into the SVC, valves and stenosis formation are 
evaluated. If there is a distal stenosis of the axillary or subclavian vein a more proximal 
entry into the vessel might be successful, although the long term risk of mechanical lead 
alteration is increased. If the subclavian vein or SVC show a central stenosis, but a proximal 
flow can still be seen, it is often possible to pass the stenosis using access to the axillary vein 
and a hydrophilic wire. A long sheath is introduced over the wire and the lead is positioned 
with the sheath still in place.  Of course the risk of occlusion of the vessel is increased 
significantly after such a procedure, but the number of intravascular leads is reduced by the 
usage of old leads compared to performing a complete new implantation on the 
contralateral side. Leads that are implanted for less than two years can often be extracted by 
conventional means, thereby further decreasing the number of remaining leads.   
In our institution an ipsilateral upgrade is pursued as general rule. Thus the contralateral 
side remains intact and is accessible for subsequent interventions, if needed, which is 
especially important for younger patients with expected long duration of implanted devices.   
If an ipsilateral upgrade is planned, the side of the old pulse generator needs to be taken 
into account as well. When upgrading a right sided pacemaker to ICD, a high-energy device 
should be used [Natale et al., 1997]. For upgrading to CRT different guiding catheters are 
needed for a right sided compared to a left sided approach.   
If the patient already has an adequate antibradycardia PM it may seem to be a theoretical 
option to implant just a new ICD-system on the contralateral side.  The pacemaker would 
keep up the antibradycardia therapy and the new ICD would act as antitachycardia system. 
The basic advantage would be to make the procedure a simpler one, equivalent in logistics 
and operation technique to the implantation of an ICD as first device. A right sided 
pacemaker combined with a new left sided ICD may offer the theoretical benefit of higher 
shock effectiveness, but that is of limited importance in view of the high energy-ICDs 
available today. However there is the disadvantage of potentially dangerous interactions. 
The elimination of these interactions cannot be guaranteed with 100% safety, even after 
extensive testing and meticulous programming. For this reason considering the up to date 
device and implantation technology, different solutions should be preferred and, if 
necessary, the patient should be transferred to a center with experience in this field.  
With an ipsilateral occluded vein the following options can be discussed:  
1. Preferably the contralateral implantation of a complete new system is done, followed by 
inactivation of the old device. The old generator is generally explanted and if the risk 
for lead removal is reasonable, the leads are extracted at the same time. Also functional 
deactivation of the old generator is possible (e.g. OOO, OVO or ODO mode) and should 
be made, if explantation is scheduled for a later time (fig. 1a to c). It has to be 
remembered that not all CIEDs allow complete deactivation (fig. 2). Principally 
deactivation by programming alone cannot be recommended as a permanent solution. 
www.intechopen.com
Adverse Interactions between ICD and Permanent Pacemaker Systems   
 
203 
Firstly, an accidental reprogramming of the generator, e.g. at a later time in ignorance of 
the specific situation cannot be excluded. Secondly, battery depletion can cause 
automatic mode changes of the old generator leading to potential interactions [Bastian 
& Kirste, 2009].  
 
         
        (a)      (b) 
Fig. 1a and 1b. Chest x-ray PA and lateral. Female patient. DDDR-pacemaker on the right 
side (Affinity®DR 5330, St. Jude Medical, St. Paul, Minnesota, USA, unipolar leads). 
Implantation in 1994 cause of sick sinus syndrome. In 2008 indication for cardiac 
resynchronization therapy (chronic heart failure due to dilated cardiomyopathy, left bundle 
branch block): new implantation of a CRT-D system on the left side (Concerto C 174 AWK, 
Medtronic Inc., Minneapolis, MN, USA) because of an occluded right subclavian vein.  
 
 
Fig. 1c. Functional deactivated unipolar dual chamber pacemaker (Affinity® DR 5330, SJM) 
by programming the device to ODO mode after the CRT-D system has been implanted on 
the opposite side.  
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Fig. 2. Functional deactivation of a unipolar single chamber pacemaker (Philos SR, Biotronik 
SE & Co. KG, Berlin, Germany).  The programming is on SSI (VVI) with a basic rate of 
30/min, minimal pacing output (impulse amplitude 0.1 V, pulse width 0.1 ms) and high 
ventricular sensitivity (1 mV). No interactions were observed until explantation 2 months 
later (same patient as in fig. 12). 
2. Contralateral implantation of a functional additive system with continued use of the 
existing device. The obvious advantage would be the relative simplicity of the 
procedure. The intervention could be carried out in centers that have less experience 
with revision procedures. Considering the potential interactions this should be 
principally avoided.  
3. Continued use of old leads with a contralateral new device could be achieved by 
subcutaneous tunneling over the sternum, but isn´t performed at our hospital anymore 
due to potential long term complications (especially mechanical lead alteration).   
4. If the ipsilateral vein is occluded and the contralateral side cannot be used e.g. because 
of infection or radiation therapy, a remaining option is extraction of the old leads using 
a sheath, which serves as a  tunnel for the new lead.  
5. The final option is the implantation of epicardial leads.  
The decision which procedure is finally chosen for a specific patient has to remain an 
individual one, of course.   
3. Interactions 
Inappropriate ICD therapy caused by oversensing of pacemaker signals 
The problem was first described by Chapman and Troup in 1986 in a patient with recurrent 
ICD shocks after “double sensing“ of bipolar DVI pacemaker actions [Sticherling et al., 1997; 
Chapman & Troup, 1986].  
The underlying mechanism is the erroneous detection of ventricular tachyarrhythmias 
caused by the ICD oversensing atrial and/or ventricular pacemaker signals, as well as the 
ventricular response or intrinsic actions (double or triple counting) (fig. 5, 6, 20, 22b). To 
become an active oversensing problem the timing of the signals has to exceed the 
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postventricular sense blanking period of the ICD, either due to programming of a long AV-
delay or a significant local conduction delay, resulting in a delay between stimulus and  
locally evoked potential  [Singer et al., 1988; Chapman & Troup, 1986; Calkins et al., 1990; 
Noguera et al., 1997]. The postventricular sense blanking period of an ICD is often around 
120-150 ms and usually cannot be programmed. However, some devices allow significantly 
lower values. The blanking period should not be programmed shorter than 100 ms to avoid 
double counting (fig. 3 and 4)!  
 
Clinical problem 
caused by interaction 
Pathophysiology =>  Mechanism of interaction 
ICD: Inappropriate 
therapy 
PM: Pacing artifacts 
- unipolar 
- with high output 
-  ineffective 
- high rate 
- asynchronous 
Noise from lead contact  
ICD: Overcounting of PM 
artifacts + evoked / intrinsic 
potentials  
=> erroneous VT/VF detection 
ICD: Inadequate 
SVT/VT discrimination 
PM: Pacing artifacts ICD: oversensing of PM 
artifacts => 
- artifact as false intrinsic 
template 
- stable tachycardia classified as 
unstable 
ICD: Delayed/inhibited 
VT/VF therapy 
PM: VT/VF undersensing 
=>  
- pacing during VT/VF 
ICD: oversensing of PM 
artifacts =>  
- VT/VF undersensing 
ICD: Inhibited post-
shock pacing 
PM: Post shock ineffective 
pacing artifacts 
ICD: oversensing of PM 
artifacts 
PM: Post-shock 
dysfunction 
- device intact 
ICD-shock =>  
energy shunted over the 
PM-lead => 
thermal damage  of 
endocardial tissue 
 
PM: 
- increased stimulation 
threshold with loss of capture  
- impaired sensing function 
PM: Post-shock 
dysfunction 
- device affected 
ICD-shock 
- high energy, applicated 
near the PM 
PM: damage or re-
programming 
- e.g. fixed rate back-up-mode 
PM: Inhibited pacing Second CIED: ineffective 
pacing 
- Frequency > PM rate 
PM: Inhibition by oversensing 
of artifacts 
Table 1. Overview: potential interactions of 2 active implanted CIEDs. PM = pacemaker, ICD 
= implantable cardioverter defibrillator, VT = ventricular tachycardia, VF = ventricular 
fibrillation.  
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Fig. 3. Double counting of wide intrinsic QRS-complexes of an induced fast ventricular 
tachycardia (VT) due to the manufacturer preset ultra short hardware blanking period of 
only 8 ms/ noise blanking of 60 ms (ICD Lexos VR-T, Biotronik SE & Co. KG, Berlin, 
Germany). After extending the blanking period to 100 ms correct sensing was registered 
(not shown on this stripe). 
 
 
Fig. 4. Intermittent ineffective ventricular ICD pacing (*) and double counting of intrinsic 
QRS-complexes (†) after shock delivery.  Postventricular sense blanking period (hardware 
blanking) 8 ms / noise blanking 60 ms (ICD Lexos VR-T, Biotronik SE & Co. KG, Berlin, 
Germany). 
Double detection as cause of inappropriate ICD-therapy has been described also with a 
biventricular ICD with simultaneous right- and left ventricular sensing [Schreieck et al., 2001].  
Additional factors that contribute to the problem of oversensing are leads that are located 
parallel or very close, unipolar pacer stimulation, high stimulation amplitude of the 
pacemaker and the use of epicardial or transvenous integrated bipolar ICD leads [Haffajee 
et al., 1996; Walker et al., 2000]. Inappropriate detection and following therapy are as well 
more likely to occur with a higher pacer stimulation rate, a lower VT/VF detection rate and 
shorter detection duration (VT/VF number of intervals to detect) of the ICD. Overall 
incidence of these interactions is very low. In 1990 a working group from Baltimore reported 
on a cohort of 30 patients with active pacemaker and ICD-systems with epicardial 
defibrillation leads [Calkins et al., 1990]. There was one case of double counting, however no 
inadequate shock was delivered. In another cohort consisting of 9 patients with epicardial 
ICD-systems, Cohen et al. showed oversensing in 5 cases, 4 patients had unipolar and 1 had 
bipolar pacemaker stimulation [Cohen et al., 1988]. In later studies with bipolar pacemakers 
and ICDs with true bipolar sensing no further cases with clinically relevant oversensing 
were described. [Sticherling et al., 1997]. However even with meticulous implantation, 
testing and best possible programming and the usage of modern systems, there is no safety 
guarantee that the interaction doesn´t show up in a particular case.  In our own cohort we 
had one patient with implanted bipolar pacemaker (Kappa DR, Medtronic) and transvenous 
ICD (Marquis VR 7230, Medtronic; lead true bipolar) who had recurrent inadequate ICD-
therapies due to double counting of the bipolar ventricular stimulation (fig. 5). Due to an 
increased stimulation threshold these stimuli were given with high energy after a long 
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stimulated AV-delay of 240 ms. Many of the sensed pacer spikes were in the refractory 
period of the ICD, which was documented in the integrity counter of the ICD (fig. 5c). The 
stored frequent episodes of non sustained VTs were caused by overcounting (fig. 5d). 
Another example of device interaction is illustrated in fig. 6. 
 
 
Fig. 5a. Inappropriate shock delivery caused by double counting. V-V interval plot.  
 
 
Fig. 5b. Inappropriate shock delivery caused by double counting. Intrinsic rhythm: sinus-arrest, 
considerable prolonged AV-conduction time (560 ms). * = intrinsic QRS-complex. PM rhythm: 
atrial pace-ventricular pace: † = paced p-Waves, ‡ = ventricular pacing artifact, prior to the 
shock ineffective due to pacing in the intrinsic ventricular refractory period. § =  after shock 
delivery (CD) effective AV-sequential ventricular pacing by the PM, sensed by the ICD. 
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Fig. 5c. More than 42.000 ultra short V-V intervals sensed at 120 or 130 ms and some 
episodes with inadequate therapy delivery caused by double counting. 1581 episodes 
counted as non sustained VT (see fig. 8). 
 
 
Fig. 5d. Frequent episodes of non sustained ventricular tachycardia: erroneous detection due 
to double counting.  
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Fig. 5e. „Spontaneous termination“ of an inadequate detected non sustained VT episode 
(monitor zone). Intrinsic rhythm: sinus-arrest, considerable intrinsic AV-conduction delay. * = 
intrinsic QRS-complex. PM rhythm: atrial pace-ventricular pace: † = paced p-Waves, ‡ = 
ventricular pacing artifact. Intermittent double counting is caused by the ineffective ventricular 
pacing artifacts as explained in fig. 5b. Depending on the timing of the p-waves to the intrinsic 
QRS-complexes safety window pacing occurs without double counting (§). The overcounting is 
interrupted after the occurrence of a second degree type I AV block (Wenckebach) (#) followed 
by AV sequential PM pacing with the pacing artifact sensed by the ICD. 
 
 
Fig. 6a. Detection of a VT in a programmed monitoring zone (marker TD VTM). Initially 
singular oversensing of a ventricular PM-spike (*). ICD: Marquis VR 7230, Medtronic, dual 
coil - true bipolar lead. ICD parameter settings for tachycardia detection: VT = Monitor 400-
330 ms; FVT = via VF 270 ms; VF = 330 ms. Wavelet = auto. Pacemaker: Kappa DR, 
Medtronic, bipolar leads. 
 
 
Fig. 6b. Detection of the VT in the VF-zone (marker FD VF) after spontaneous acceleration 
with change of morphology and intermitting  overcounting (*) of  ventricular PM actions (†). 
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Fig. 6c. Termination of the VT by ICD shock (marker CD) after a second change of cycle 
length and morphology. The pacemaker artifacts (*) were not double counted.  
Other situations where double counting can be encountered are ventricular sensing failure 
with asynchronous stimulation of the pacemaker in competition with the intrinsic rhythm 
[Singer et al., 1988], automatic or manual pacing threshold testing (fig. 27), asynchronous 
magnet testing [Brode et al., 1997; Epstein et al., 1989] as well as - independent of 
interactions-T-wave oversensing (fig. 7). Multiple counting can be caused by interference 
signals e.g. with a fractured lead (fig. 8) or mechanical lead-lead contact [Brode et al., 1997].  
As a new, currently still experimental technology the combination of a device for cardiac 
contractility modulation (CCM) with an ICD, pacemaker or CRT-system is possible and 
useful [Seifert et al., 2008]. Of course it must be ensured that the CCM-signals are not being 
sensed by the second device.  
 
 
Fig. 7. Inappropriate ICD-therapy due to T-wave oversensing (*). ICD Atlas®DR V 240, SJM. 
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Fig. 8. Inappropriate ICD-therapy (30 J, ICD Lexos VR-T, Biotronik) due to ICD lead fracture 
(Sprint fidelis 6948, dual coil, Medtronic). Multiple artifacts in the pace-sense channel 
(bottom). The upper far field EGM shows no artifacts. Note that sensing (*) as well as 
ventricular pacing (†) function is also affected.  
Another clinical interaction hasn´t been described in the literature so far: modern ICDs have 
different algorithms for differentiation of supraventricular and ventricular 
tachyarrhythmias. This includes taking a sample template of the normofrequent intrinsic 
chamber complex as a reference which is then compared to the morphology of a 
tachycardia.  A match supports more a supraventricular tachyarrhthymia whereas in the 
case of a mismatch, the algorithm supports more the ventricular origin. Usually this 
template is automatically updated. With frequent oversensing of pacemaker stimulus 
artifacts by the ICD, such a stimulus may be erroneously recognized as ´intrinsic QRS 
complex` and saved as reference (Fig. 9). This could lead to misinterpretation of a 
supraventricular tachyarrhythmia as VT. 
 
    
Fig. 9. Ventricular pacing artifact (*) erroneously saved as reference (template) for  intrinsic 
chamber complex during automatic wavelet update (pacemaker Kappa DR, ICD Marquis 
VR 7230, Medtronic). † = true intrinsic QRS complex 
Pro-arrhythmic effects of inadequate ICD-therapies have also been described [Sticherling et 
al., 1997; Epstein et al., 1989; Pinski & Fahy, 1995] (fig. 10).  
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Fig. 10. Induction of non sustained VT by inadequate ICD-shock 
Undersensing of ventricular tachyarrhythmia by the ICD 
This problem is the most serious potential interaction. For safe recognition of   VF with a low 
intrinsic amplitude today´s ICDs have high sensitivity, which adjust automatically to the 
perceived signal up to a programmed maximum value.  The automatic adaptive sensing 
algorithms of different manufacturers have specific characteristics and are programmable to 
some extent. If a pacemaker programmed according to normal standards (e.g. with 
ventricular sensing of 2.5 mV with bipolar systems or less sensitive with an unipolar lead) 
doesn´t recognize VF because of the low amplitude, the pacemaker will stimulate with its 
basic rate or sensor rate (fig. 11a). This is also true for AAI-pacemakers, that usually don´t 
sense any signals from the ventricle, if they are not inhibited by far-field-signals [Singer et 
al., 1988] These stimulation artifacts can now be sensed by the highly sensitive ICD. 
Especially with unipolar pacing spikes with high amplitude, the automatic sensing 
threshold is changed to less sensitive values. The consequence may be undersensing of VF 
with the worst case scenario of the ICD withholding therapy (fig. 11b).  
 
 
Fig. 11a. Undersensing of ventricular fibrillation during cardiac catheterization in a patient 
with unipolar DDD-pacemaker stimulation.  
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Fig. 11b. Effective ICD shock is delivered after a marked delay of 25 seconds.  Subsequent 
loss of capture (*) and sensing failure of the implanted DDDR-pacemaker (†).  
Although some authors think it is in principle possible to use unipolar pacemaker leads 
when careful implantation and testing are performed [Haffajee et al., 1996], the general 
opinion states a contraindication for unipolar pacemaker stimulation if there is a second 
active CIED present [Singer et al., 1988; Epstein et al., 1989;  Mattke et al., 1997] (fig. 12).  
Although for many years there´s a predominant use of bipolar leads for conventional 
pacemakers, unipolar left ventricular leads are still used in implantation of CRT systems 
because of the venous anatomy. (fig. 13). The unipolar left ventricular stimulation generates 
a large pacing dipole [Le Franc et al., 1998]. 
 
 
Fig. 12. Chest x-ray PA. Male patient,  VVIR-pacemaker on the right side (Philos SR, 
Biotronik, implantation of unipolar lead 1975 cause of AV-Block III°). In August 2008: new 
implantation of a singular chamber ICD on the left side (Maximo VR, Medtronic) because of 
spontaneous VT with syncope, occluded right sided vein and permanent atrial fibrillation. 
Explantation of the pacemaker in October 2008.  
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                                       (a)                                                                              (b) 
Fig. 13 a and b. Chest x-ray PA and lateral. Implantation of a biventricular pacemaker  CRT-
P (Insync III 8042, Medtronic) in November 2005 in a patient with  dilatated 
cardiomyopathy. The unipolar LV-lead is positioned in an unfavoured anterolateral way. 2 
years later contralateral implantation of a singular chamber ICD (Lexos VR, Biotronik) as 
bridge to heart transplant. The bipolar right ventricular leads were placed very close 
together. However, testing showed no inhibition of the ICD dectecting induced ventricular 
fibrillation during pacemaker stimulation.  
The problem was already described by Kim et al. in 1986 [Sticherling et al., 1997; Kim et al., 
1986]. Among the 30 Baltimore patients inhibition of VF therapy was found in 2 patients 
with unipolar pacemakers and in one patient with a bipolar pacemaker under testing with 
high asynchronous output [Calkins et al., 1990]. Van Casteren et al. recently reported a case 
of temporary VF undersensing by a dual chamber ICD caused by oversensing of unipolar 
PM artifacts leading to delayed ICD therapy at defibrillation testing [Van Casteren et al., 
2009]. So far there hasn’t been a description of therapy inhibition of VF by oversensing in the 
clinical course of patients with bipolar pacemakers with standard programming and true 
bipolar transvenous ICDs and for example there was no occurence in the 4 patients 
observed by Sticherling et al. It has to be pointed out however that there might be the 
necessity to increase the stimulation energy due to future threshold increases, which will 
increase the possibility of interactions.  
There are 3 further phenomena that were reported by Glikson et al. and resulted from 
asynchronous pacemaker stimulation during tachyarrhythmias while testing [Glikson et al., 
1999]: 1. A fast VT was detected in a slower zone and therefore firstly treated with ATP 
ineffectively.  2.  A VT was detected in the VF-zone due to oversensing of pacemaker-stimuli 
and VT-complexes (see fig. 6b). 3. A stable VT-cycle length was classified as instable and the 
VT detection prevented as the stability criterion was activated.  
Inhibition of antibradycardia ICD-function 
In the presence of 2 active CIEDs the stimulation of the pacemaker at the basic or sensor rate 
will inhibit the antibradycardia function of the ICD, which will work, as intended, only as 
the antitachycardia system. If the ventricular stimulation by the pacemaker should be 
ineffective, the ICD can act as a backup for antibradycardia stimulation with its (usually 
low) programmed basic rate. However, this ICD stimulation can be inhibited by oversensing 
of pacemaker stimuli resulting in a loss of the backup function. A clinical example is the 
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inhibition of antibradycardia ICD back up stimulation by ineffective pacemaker artifacts 
after shock therapy (fig. 15, 24). The interaction can also be troublesome when e.g. a patient 
fitted with an AAI-pacemaker for sick sinus syndrome has received a VVI-ICD (fig 14).  In 
case of a new AV-block the ICD could at least maintain ventricular stimulation - of course 
with loss of AV-synchronicity-, but there is the theoretical possibility of inhibition of ICD-
stimulation by oversensing of atrial pacemaker spikes. 
 
 
Fig. 14. Chest x-ray PA. Male patient, ICD implantation for secondary prevention (Marquis VR 
7230, Medtronic, lead dual coil true bipolar). Three years later implantation of a bipolar AAIR 
pacemaker (Insignia I Ultra, Boston Scientific) on the right side because of sinus bradycardia 
with preserved atrioventricular conduction. The left subclavian vein was found to be occluded.  
Shock-induced pacemaker dysfunction 
Increase of stimulation and/or sensing threshold of pacemaker 
Immediately after shock delivery there may be in rare cases an increase in stimulation 
threshold with loss of capture and/or impaired sensing function (fig. 11b, 15, 23b, 24).  
The mechanism of these phenomena remains unclear. Either a shunting of current to the 
pacing lead by activation of zener diode and/or capacitive  coupling of energy to the lead 
resulting  in a local thermal damage at the electrode-myocardial interface are discussed 
[Sticherling et al., 1997; Calkins et al., 1990; Levine et al., 1983]. The dysfunction is generally 
only transient and is more common with external defibrillation than with internal shocks. 
Shocks with higher energy seem to cause a higher increase in stimulation threshold 
(compare fig. 22b and 23b) [Sticherling et al., 1997; Brode et al., 1997; Pinski & Fahy, 1995].  
Among the 30 patients described by  Calkins et al. there was a transient impairment of 
pacing and/or sensing in 7 cases with a duration of  < 10 seconds in  4 patients, < 35 seconds 
in 2 patients and  > 56 seconds in 1 patient. In another case with a unipolar pacemaker the 
sensing defect lasted > 10 minutes, the lead was changed to a bipolar one. [Calkins et al., 
1990]. None of the dysfunctions had a clinical impact on the patients, 5 of the 7 patients had 
ICD therapies in the follow up without any noticeable adverse interactions. Mattke et al. 
reported 10 patients, with no one having transient or persisting loss of capture or sensing 
after ICD-shock delivery [Mattke et al., 1997].  
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Fig. 15. Immediately after delivery of a 31 J-shock for termination of VF the transient 
ineffective ventricle stimulation (*) of the pacemaker (Kappa DR 401; Medtronic) can be seen 
in the ventricular pace-sense-channel (top) as well as in the ventricular electrogram of 
defibrillation coils (bottom) of the ICD (Ventak Prizm 2VR 1860; Guidant).  The ICD detects 
the stimulation artifacts but not the following chamber complexes. ICD post shock pacing is 
inhibited by oversensing of the pacemaker stimuli. 
Damage to or reprogramming of the pacemaker 
This interaction is rarely described in the literature [Glikson et al., 1999; Gould et al., 1981]. 
Calkins et al. reported in 1990 three patients with reprogramming of the pacemaker to a 
back-up mode after ICD-shocks using epicardial high-voltage-electrodes [Calkins et al., 
1990]. In contrast Geiger et al. published in 1997 5 patients out of 37 (13.5%) with a 
transvenous ICD, who showed on follow-up testing a reset of the pacemaker to baseline 
parameters (VOO bipolar) after shocks  > 20 J [Geiger et al., 1997].  In the cohort of Mattke et 
al. one case of transient pacemaker-reprogramming was seen, the complication was never 
seen in pacemakers with a protective circuit [Mattke et al., 1997].  
It is not known, if the current pacemaker generation can be damaged by shock delivery of 
high energy ICDs. If the subcutaneous ICDs, that are currently being developed, become 
available, the potential of interactions of these high energy shocks with additionally 
implanted pacemakers has to be considered. 
4. Implantation 
The prevention of potential interactions already starts with the implantation.  
1. Only bipolar pacemaker leads and true bipolar ICD leads should be used [Brooks et al., 
1995; Sheahan et al., 1997]. Unipolar pacemaker leads and ICD leads with pseudo-bipolar 
sensing increase the risk of interactions and are therefore contraindicated [Brooks et al., 
1995; Cohen et al., 1988; Epstein et al., 1989; Mattke et al., 1997; Kim et al., 1986]. In 
addition it has to be pointed out, that during bipolar pacing the paced signal amplitude is 
directly related to the interelectrode separation on the pacing lead [Brode et al., 1997].  
2. A parallel position of the leads increases far-field detection of pacemaker stimulus 
artifacts by the ICD lead and should therefore be avoided [Brooks et al., 1995]. A 
maximum lead distance of at least 2-3 cm and a 90° orientation of the pacemaker 
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dipoles should be pursued [Geiger et al., 1997; Sheahan et al., 1997]. For this reason it is 
mandatory to control the positioning of the leads in 2 planes. (fig. 16). 
 
    
                                       (a)                                                                               (b) 
Fig. 16 a and b. Chest x-ray PA and lateral: unfavourable positioning of ventricular 
electrodes to avoid oversensing: parallel position, very small distance < 1 cm. 
(Pacemaker/CRT-P: InSync, Medtronic. ICD: Lumax 300 VR-T, Biotronik) 
To achieve a long distance e.g. the repositioning of a ventricle lead from the right 
ventricular apex (RVA) to a new position at the septum respectively in the right 
ventricular septal outflow tract (RVOT) seems reasonable (fig. 12) [Mattke et al., 1997]. 
However, an approach that is just guided by the anatomy is not sufficient on its own to 
prevent interactions [Brooks et al., 1995; Mattke et al., 1997]. Already at leads 
positioning the far-field-detection of pacemaker-spikes in the EGM and marker-channel 
of PSA, and after connection with the ICD should be watched. If necessary a different 
lead position has to be achieved [Cohen et al., 1988; Epstein et al., 1989] (fig. 17).  
 
 
Fig. 17. EGM during implantation: newly implanted ICD-lead with marker-annotation 
(Analyser 2290, Medtronic, paper speed 25 mm/s), sensitivity 2.5 mV. The ventricular 
pacemaker spikes are shown with amplitude between 1 to 5.5 mV. With a QRS amplitude of 
about 9 mV no double-counting is observed, the stimulation artifacts were not sensed. 
3. Leads with active fixation have the advantage of stable positioning in any location and 
should therefore be preferred [Sticherling et al., 1997]. 
5. Testing 
Extensive testing for interactions is an essential part of the implantation procedure, if two 
CIEDs are left active [Sticherling et al., 1997; Walker et al., 2000; Cohen et al., 1988; Glikson 
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et al., 1999; Blanck et al., 1994]. This is also necessary even if the explantation of one device is 
already planned and the presence of the two devices together is of limited duration. If a 
CCM device is to be combined with a second active CIED (e.g. CRT-D) testing for 
interactions is also mandatory [Seifert et al., 2008]. Real time telemetry is particularly helpful 
with its view of high resolution intracardiac electrogram (EGM) and marker annotations. In 
practice a structured step by step approach is helpful. An exemplary protocol was evaluated 
by Glikson et al. and was used by others in a modified form [Sticherling et al., 1997; Walker 
et al., 2000; Cohen et al., 1988; Glikson et al., 1999; Blanck et al., 1994]: 
1. Assessment of oversensing of pacemaker artifacts: the predominant criterion to accept a 
newly positioned ventricular lead is the analysis of pacemaker spikes by the ICD. 
Therefore, the pacemaker is programmed for stimulation with maximum amplitude 
and pulse width for all connected leads. With dual or triple chamber leads a long AV 
delay is selected. Now under stimulation, the EGM of the ICD lead is analyzed using 
maximum sensitivity and watched for oversensing of pacemaker actions. If there is 
double or triple sensing it is suggested to first reduce the pulse width and then if 
necessary the amplitude of the pacemaker until no oversensing is seen any more 
[Sticherling et al., 1997]. If this setting is not sufficient for effective pacing with enough 
safety margins, then the lead has to be newly positioned. To avoid oversensing not only 
the absolute amplitude of the pacemaker – stimulation – artifact is of importance, but 
also the ratio of signal heights of spikes to the evoked potential respectively the intrinsic 
chamber complex (fig. 17, 18). The test protocol evaluated by Glikson et al. regarded 
stimulation artifacts > 2 mV or a ratio of stimulus artifact/evoked QRS > 1/3 as 
insufficient. [Cohen et al., 1988; Glikson et al., 1999]. The authors described a positive 
predictive value of 18% respective 14.4% for clinical relevant interactions and a negative 
predictive value of 100% respective 92.3%.  
If there is oversensing in the EGM of the ICD, the time interval from ventricular 
pacemaker spike to evoked QRS complex has to be shorter than the postventricular 
sense blanking period of the ICD (fig. 22b) [Cohen et al., 1988].  
 
 
 
Fig. 18. Oversensig of the high ventricular pacing artifact (amplitude 12.5 mV) by the ICD. 
The stimulus artifact : evoked QRS ratio was inacceptably high (2.1). The atrial spikes as 
well as the QRS-complexes were not sensed.  
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2. Rule out of VT/VF detection inhibition: correct ICD-detection of induced VF has to be 
checked when there is asynchronous pacemaker stimulation. The pacemaker is set to a 
fixed rate mode (VOO or DOO) with – for each individual patient - the highest 
stimulation rate, maximum stimulation energy (with just no oversensing) and with 2- or 
3-chamber devices with long AV–delay. During induced VF the EGM is analyzed, if 
ICD -detection and consecutive therapy of ventricular tachyarrhythmia are influenced 
by the pacemaker stimulation (Fig. 19). It´s recommended to test at least twice and with 
standard clinical as well as maximum ICD sensitivity. 
 
 
Fig. 19a. ICD testing. The ICD (Marquis VR 7230, Medtronic) was programmed to low 
sensitivity. The pacemaker (Kappa DR, Medtronic) with bipolar leads stimulates in DDD-
mode with high pacing energy. Following induction of VF by t-wave shock (*) intermittend 
VF-undersensing occurs (†). However VF was detected and terminated by effective 
defibrillation (**). Before and after the test the ventricular pacing spike (not the QRS-
complex) is sensed by the ICD (‡). Atrial pacing is to be seen in the EGM, but not sensed by 
the ICD. Paper speed 12.5 mm/s. 
 
 
Fig. 19b. The pacemaker was programmed to higher sensitivity and lower pacing energy. 
Then the ICD was programmed to higher sensitivity and tested again. This time the induced 
VF showed higher amplitudes and terminated after ATP and organization to monomorphic 
VT. During the tachyarrhythmia oversensing of the pacing artifact and relevant VF-
undersensing occurred only infrequently (†). The ventricular pacing spike was still sensed 
by the ICD before and after the test (‡). Paper speed 12.5 mm/s. 
3. Analysis of VF-detection by the pacemaker:  After completion of steps 1 and 2 testing of 
effectiveness of defibrillation e.g. as limited safety margin test can follow.  The ICD is 
programmed to clinical sensitivity and e.g. to a shock energy with a safety margin of ≥ 
10 J. At the same time the pacemaker is set to clinical parameters (see programming). 
Shock effectiveness is analyzed as well as the correct detection of induced VF by the 
pacemaker, to primarily avoid fixed rate pacemaker stimulation during ventricular 
tachyarrhythmias (Fig. 20 to 24). If there is asynchronous stimulation during VF, the 
event markers of the pacemaker are examined to distinguish undersensing from „noise 
reversion“. According to the results, sensitivity and refractory periods of the pacemaker 
need to be adjusted.   
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Fig. 20. Proper detection and termination of induced VF by a single chamber ICD (Lexos VR-
T, Biotronik) in an patient with a combined CRT-P-system using an unipolar lead for left 
ventricular pacing (InSync III, Medtronic. Basic rate 60/min, paced AV-delay  170 ms, 
interventricular delay 4 ms). Only the first beat after the shock shows triple counting (*): the 
ICD sensed two pacing artifacts and the evoked QRS complex. 
 
 
Fig. 21. Nearly continuous undersensing of ventricular flutter/fibrillation by an unipolar 
single chamber VVI pacemaker. (VF induced in the EP-laboratory. HRAp = high right 
atrium, RV = right ventricle)  
 
 
Fig. 22a. Correct  ventricular sensing (VS) of an induced fast VT (CL 240 ms) by a dual 
chamber pacemaker (Kappa KDR 700, Medtronic). Paper speed 25 mm/sec. 
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Fig. 22b. Same episode as fig. 22a. The EGM of the ICD (Ventak Prizm DR HE 1853, 
Guidant/BSCI) showed no oversensing of PM-actions during the VT, as the PM is inhibited. 
After correct termination with 21 J there is once double counting immediately after shock 
(atrial (*) and ventricular (†) pacing artifact). Thereafter the ventricular PM stimulus is 
detected by the ICD (‡), the evoked chamber complex falls into the blanking period.   
 
 
Fig. 23a. Complete undersensing of induced VF by the PM in the same patient as in fig. 22. * 
= t-wave shock for VF induction. Paper speed 25 mm/sec. 
 
 
Fig. 23b. Intermitting undersensing of induced VF by the ICD resulting from oversensing of 
ventricular actions of the PM (*).  After high energy shock (41 J) transient PM dysfunction († 
= defect of sensing, ‡ = ineffective pacing). 
4. Assessment of pacemaker function after shock delivery:  After all ICD-therapies sensing and 
effectiveness of PM stimulation are evaluated. Especially in patients who are 
permanently dependent on their pacemaker a loss of capture has to be looked out for 
and the programming of the ICD should include prolonged post-shock stimulation to 
increase the safety. Proper function of the programmed ICD post shock pacing has to be 
verified (fig. 4, 15). Finally, reprogramming or damage to the PM need to be excluded. 
[Pinski & Fahy, 1995].  
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Fig. 24. Despite unipolar single chamber PM stimulation induced VF is correctly terminated 
by the ICD.  However, after effective defibrillation there is continued ineffective PM 
stimulation as well as undersensing of intrinsic ventricular actions. (VF induced in the EP-
laboratory. HRAp = high right atrium, RV = right ventricle) 
“An absence of device interaction during implantation and testing procedures does not completely 
exclude the possibility of this occurring in the clinical setting…” [Blanck et al., 1994] 
6. Programming and follow up 
There are special points that need to be taken into account for the permanent programming 
of the two active devices to avoid future interactions.  
1. As already emphasized, unipolar PM-stimulation has to be absolutely avoided.  This also 
means that the commonly used practice to program bipolar sensing with unipolar 
stimulation for better visibility of PM-spikes in routine EKGs must not be done.  Modern 
pacemakers have safety algorithms, which will switch permanently to unipolar 
stimulation, if there is a bipolar lead defect. This feature has to be deactivated (fig. 25). 
 
 
Fig. 25. Example of PM-programming for combined use together with a separate ICD to 
avoid interactions with bipolar lead configuration and high ventricular sensitivity. 
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The safety switch of the PM has to be deactivated to prevent automatic change to 
unipolar stimulation. In this demonstrated example of BSCI the lead configuration 
programming window shows the warning: “Safety Switch may result in unipolar 
pacing, which is contraindicated for ICD patients“. 
2. Increased sensitivity of the ventricular PM lead is programmed to guarantee pacemaker 
detection of ventricular tachyarrhythmias with low amplitude and therefore the 
occurrence of fixed rate stimulation is prevented, especially during VF [Cohen et al., 
1988; Blanck et al., 1994].  However it is important to rule out oversensing of 
myopotentials by provocation testing especially in patients who are permanently 
dependent on their pacemaker. In our experience programming  1 mV is safe and 
effective with the modern leads. Automatic adaption of sensitivity should be 
deactivated (fig. 25). 
3. Modern pacemakers feature algorithms to increase the stimulation rate if needed.  
Examples include sensor response or rate smoothing as well as algorithms for 
prevention and therapy of atrial tachyarrhythmias. The maximum rate of PM-
stimulation must not exceed the detection rate of the ICD, as this could lead to 
inadequate detection of tachycardias and possible ICD-therapy [Brode et al., 1997; 
Blanck et al., 1994; Chamberlain-Webber et al., 1994].  
4. In the presence of ICD-double counting, the first step is to analyze the EGM and see 
which signals are being detected by the ICD.  Possible sources include atrial and/or 
ventricular PM-spikes, right- and if applicable left-ventricular evoked or intrinsic 
potentials, T-waves, and other different artifacts. Then the following questions need to 
be answered:  
a. How are the leads of the two devices positioned to each other? What kind of leads 
are in use? 
b. Is the PM-stimulation unipolar and/or with too high energy? Are any algorithms 
for automatic polarity switch or stimulation energy increase or impedance 
measuring active? 
c. Is the double-counting caused by too long conduction times, e.g. long AV-delay or 
long intra- respective interventricular disturbance of conduction or a long QT time? 
Are the programmed refractory periods too short? 
Depending on the cause of oversensing, changing the programming might solve the 
problem:  
a. Unipolar stimulation with high energy has to be avoided, automatic 
settings/changes deactivated (if necessary).  
b. It might help to increase the ventricular blanking period of the ICD and to adapt 
the automatic detection. The reliable detection of VF has to be ensured (fig. 26)! 
c. If there is oversensing of atrial or ventricular signals with long AV-delay of the PM, 
a shortening of the AV-delay is to be considered. However a short AV-delay may 
deteriorate the hemodynamic situation and the proportion of ventricular 
stimulation can be increased, which is usually not desired. 
d. In patients with an implanted 2-chamber PM or singular chamber-ICD and 
preserved  AV-conduction, who have  oversensing of  ventricular spikes of the PM, 
the programming of a long AV-delay may be considered to promote intrinsic AV  
conduction and thereby avoid overcounting of ventricular stimulation artifacts 
[Sheahan et al., 1997].  
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Fig. 26. Undersensing of a VT (induced by T-wave-shock) after reduction of ICD-sensitivity  
(Ventak Prizm 2VR 1860; Guidant) as reaction to overcounting of PM artifacts (Kappa KDR 
401; Medtronic, bipolar leads!).  The PM artifacts can be seen in the ventricular pace-sense-
channel (top) as well as in the ventricular EGM of the defibrillation coils (bottom) and are 
being detected inconstantly by the ICD.  
e. The reprogramming of a DDD(R)-pacemaker to AAI(R)-mode, if the AV-
conduction is intact, was recommended by  Brooks et al. and  Chapman et al. to 
avoid interactions caused by oversensing of  ventricular pacemaker stimuli [Brooks 
et al., 1995; Chapman & Troup, 1986].  
f. Another last programming option with  double-counting of PM spikes would be  - 
if clinically possible in the individual patient  - to limit the upper range of PM 
stimulation rate to less than half of the detection rate of the ICD [Chapman & 
Troup, 1986]. 
However, if oversensing with a clinical relevance can´t be avoided by programming, a 
revision of the system must be pursued. 
5. The stimulation output of the PM should be minimized just ensuring an adequate safety 
margin for effective pacing [Blanck et al, 1994]. Thus the individual stimulation energy 
has to take the results of the threshold and interaction testing into account. In PM with 
automatic adaption of stimulation amplitude and pulse width the maximum value of 
adaptive stimulation energy has to be limited. Attention also needs to be paid to the fact 
that the automatic measurements of lead impedance are being conducted with higher 
energy (e.g. 5 volt). If there is oversensing with higher stimulation energies this 
automatic measurement has to be deactivated.  
Caution is warranted in performing the pacemaker threshold testing in the presence of an 
active ICD.  The stimulation with higher rates and energy can lead to inappropriate 
therapy due to oversensing of stimulation artifacts and of evoked and/or after loss of 
capture intrinsic QRS complexes [Cohen et al., 1988; Epstein et al., 1989; Azizi & Nägele, 
2007]. This is particularly important for CRT-systems with a unipolar left ventricular (LV) 
lead (fig. 27). Principally the EGM of the ICD has to be watched for oversensing during 
testing. Some authors even recommend deactivation of the ICD during pacemaker testing 
[Singer et al., 1988], especially for CRT-PM-systems [Azizi & Nägele, 2007].  
Depending on the testing results automatic threshold tests have to be turned off. 
6. During programming of the detection criteria of the ICD, the avoidance of inadequate 
therapy deliveries have to be watched.  Therefore - if clinical possible in the individual 
patient – a high VT/VF-detection rate and long detection durations should be 
programmed in the respective zones. The morphology as well as the stability criterion 
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for discrimination of SVTs should be used only, if an erroneous registration of PM 
artifacts by the ICD can be surely excluded (fig. 9). It is recommended to check the 
reference for intrinsic chamber complexes during device control and to deactivate 
automatic update. In patients with permanent high degree AV-Block the SVT-
discrimination can be omitted. 
7. In patients who are dependent on their pacemaker, the duration of post-shock pacing 
by the ICD with high stimulation energy should be extended. This will guarantee 
effective stimulation, if there is an increase of stimulation threshold of the 
antibradycardia pacemaker after the ICD shock [Singer et al., 1988; Pinsky & Fahy, 
1995]. 
8. The specific details of programming have to be mentioned in the report and there must 
be references in the device card. As the combined use of two active CIEDs is rare, a lot 
of doctors might not be aware of all the problems and issues involved and therefore 
might change the programming to a more standard programming in ignorance of the 
specific situation.  
 
 
 
Fig.  27 a and b. Inappropriate shock (CD) due to double counting of stimulation artifacts of 
the unipolar LV lead (*) and  the evoked potentials (†) at LV stimulation for threshold 
testing (ICD Marquis VR 7230; CRT pacemaker InSync III, Medtronic). 
7. Conclusion 
As there is no definitive guarantee for long term elimination of interactions and considering 
the modern technology, the combined use of two separate active CIEDs should be 
principally avoided.  If in an individual case e.g. for a limited time after system upgrade the 
indication for a dual device therapy is seen, careful implantation, extensive testing and 
specific programming are essential to minimize the risk of possible dangerous adverse 
interactions.  
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There is a possibility that this currently rare problem will regain more clinical impact, when 
emerging new technologies, such as devices for cardiac contractility modulation, 
subcutaneous high energy ICDs without antibradycardia therapy or endocardial fixated 
“leadless pacemakers”, are further developed and are used in clinical routine. 
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